 FLORHAM PARK, N.J., Oct. 27, 2021 GLOBE NEWSWIRE -- PDS Biotechnology Corporation Nasdaq: PDSB, a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease vaccines based on the Companys proprietary Versamune T-cell activating technology, today announced that the companys Chief Medical Officer, Dr. Lauren V. Wood, will be presenting at the upcoming 2021 International Head and Neck Cancer Conference hosted by Cardiff, NHS Wales and The Swallows Head Neck Cancer Support Group. 